浙江医药：2025年前三季度归属于上市公司股东的净利润同比增长9.83%

Core Insights - Zhejiang Medicine reported a revenue of 6,695,297,924.39 yuan for Q3 2025, representing a year-on-year decline of 5.87% [1] - The net profit attributable to shareholders of the listed company was 933,147,906.73 yuan, showing a year-on-year increase of 9.83% [1] Financial Performance - Revenue for Q3 2025: 6.70 billion yuan, down 5.87% year-on-year [1] - Net profit for Q3 2025: 933.15 million yuan, up 9.83% year-on-year [1]